Back pain: empirical and personalized approach to drug therapy. Conclusion of the Expert Council of the Russian Society for the Study of Pain

Objective. To present the recommendations of the expert council of the Russian Society for the Study of Pain on “Dorsumio” drug in the treatment of chronic nonspecific back pain (CNBP). Key points. Currently, CNBP is the leading disease associated with disability worldwide. Patients with CNBP often experience concomitant depressive and anxiety symptoms complicating the course of disease and therapy, as well as worsening the quality of life and working capacity. Various problems in care for CNBP include not only the impact on pathogenesis of chronic pain, but also treatment of depression, anxiety, insomnia, assessment of compatibility of various drugs and patient adherence to therapy. The new drug “Dorsumio” (mirtazapine 15 mg + tizanidine 6 mg) can influence on chronic pain mechanisms and provide effective therapy for patients with chronic nonspecific back pain due to complex analgesic, muscle relaxant, antidepressant and anti-anxiety effects.

Authors

Institutions

Publication Details

Journal
Russian Journal of Pain
Published
2025-03-13
DOI
https://doi.org/10.17116/pain20252301192
Citations
1
Primary Topic
Musculoskeletal pain and rehabilitation
Type
article
Field-Weighted Citation Impact
1.39
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Back pain: empirical and personalized approach to drug therapy. Conclusion of the Expert Council of the Russian Society for the Study of Pain

E Z Yakupov, С. А. Живолупов, Maxim V. Churyukanov, А. Г. Бениашвили et al.
1 citations
Russian Journal of Pain
Musculoskeletal pain and rehabilitation
1.39
article

Back pain: empirical and personalized approach to drug therapy. Conclusion of the Expert Council of the Russian Society for the Study of Pain

E Z Yakupov, С. А. Живолупов, Maxim V. Churyukanov, А. Г. Бениашвили, И. Г. Козлов, Ф. И. Девликамова, Danilov Ab, Olga V. Kurushina, Yury P. Sivolap, D. A. Iskra, О.С. Давыдов, Е. Р. Баранцевич, П Р Камчатнов, Mikhail Lvovich Kukushkin, Л. Т. Ахмеджанова, Andrey Petrovich Rachin, V.A. Shirokov, Yu. V. Karakulova, А. Е. Барулин, А. В. Амелин, М. И. Карпова
article en
1 citations

Abstract

Objective. To present the recommendations of the expert council of the Russian Society for the Study of Pain on “Dorsumio” drug in the treatment of chronic nonspecific back pain (CNBP). Key points. Currently, CNBP is the leading disease associated with disability worldwide. Patients with CNBP often experience concomitant depressive and anxiety symptoms complicating the course of disease and therapy, as well as worsening the quality of life and working capacity. Various problems in care for CNBP include not only the impact on pathogenesis of chronic pain, but also treatment of depression, anxiety, insomnia, assessment of compatibility of various drugs and patient adherence to therapy. The new drug “Dorsumio” (mirtazapine 15 mg + tizanidine 6 mg) can influence on chronic pain mechanisms and provide effective therapy for patients with chronic nonspecific back pain due to complex analgesic, muscle relaxant, antidepressant and anti-anxiety effects.

Russian Journal of PainVol. 23(1)
Peoples' Friendship University of Russia (RU), Volgograd State Medical University (RU), Sechenov University (RU), First Pavlov State Medical University of St. Petersburg (RU), S. M. Kirov Military Medical Academy (RU), Chelyabinsk State Medical Academy (RU), Pirogov Russian National Research Medical University (RU), Perm State Medical Academy (RU), Ural State Medical University (RU), Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology (RU), Kazan State Medical Academy (RU), Research Institute of General Pathology and Pathophysiology, the Russian Academy of Medical Sciences (RU), Russian Scientific Center of Surgery (RU), Saint Petersburg State Pediatric Medical University (RU)
Openalex Percentile: Top 23%
Musculoskeletal pain and rehabilitation
1.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.